A
VRTX icon

AlphaQuest’s Vertex Pharmaceuticals VRTX Stock Holding History

AlphaQuest’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-661
Closed -$300K – 2045
2025
Q4 		$300K Sell
661
-355
-35% -$153K 0.02% 1211
2025
Q3 		$398K Buy
1,016
+561
+123% +$234K 0.03% 965
2025
Q2 		$203K Buy
455
+72
+19% +$33.2K 0.02% 1123
2025
Q1 		$186K Sell
383
-134
-26% -$62.4K 0.02% 1035
2024
Q4 		$208K Sell
517
-2,767
-84% -$1.28M 0.03% 852
2024
Q3 		$1.53M Buy
3,284
+3,201
+3,857% +$1.54M 0.14% 219
2024
Q2 		$38.9K Sell
83
-2,389
-97% -$1.04M 0.01% 1152
2024
Q1 		$1.03M Buy
2,472
+2,392
+2,990% +$1.01M 0.18% 184
2023
Q4 		$32.6K Buy
+80
New +$29.6K 0.01% 929

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

AlphaQuest's VRTX Position: Q1 2026 in Review

AlphaQuest sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 661 shares — an estimated $300K sold.

AlphaQuest first reported a position in VRTX in Q4 2023 and held it in 9 quarters. The position peaked at $1.53M in Q3 2024. 1,698 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • AlphaQuest reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 661 Vertex Pharmaceuticals shares in Q1 2026, an estimated $300K.
  • AlphaQuest first reported a position in Vertex Pharmaceuticals in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Vertex Pharmaceuticals position peaked at $1.53M in Q3 2024.
  • 1,698 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.